B2B RESEARCH PORTAL · ACCESS LIMITED TO VERIFIED ORGANIZATIONS

QUALITY SYSTEM · PRELIMINARY FRAMEWORK

Release decisions need
evidence and ownership.

PMBio Labs is designing a controlled process that separates supplier claims from verified records and prevents a catalog listing from being mistaken for a released material.

PRELIMINARY Catalog record only
QUARANTINED Review incomplete
RELEASED Approved for eligible accounts
WITHDRAWN Availability removed

SIX CONTROL GATES

Nothing moves forward
on a badge alone.

These controls are planned operating requirements. They do not claim that PMBio Labs currently holds qualified inventory, laboratory agreements, certifications, or regulatory approval.

01

Regulatory assessment

Review the specific material, customer category, intended research scope, and every jurisdiction served.

FRAMEWORK
02

Supplier qualification

Verify legal entity, manufacturing relationship, traceability, specifications, change controls, and quality documentation.

FRAMEWORK
03

Incoming controls

Quarantine each received lot, reconcile identifiers, inspect packaging, and preserve chain-of-custody records.

FRAMEWORK
04

Analytical review

Evaluate laboratory identity, sample relationship, methods, raw result context, dates, and specification alignment.

FRAMEWORK
05

Release decision

A designated reviewer records approval, rejection, or hold status before any availability is displayed.

FRAMEWORK
06

Ongoing surveillance

Maintain complaint, deviation, withdrawal, document-revision, and account-monitoring records.

FRAMEWORK

EVIDENCE HIERARCHY

A report is useful only
when its relationship is clear.

A published record should let a qualified customer determine what was tested, who tested it, when it was tested, which method was used, which acceptance criteria applied, and whether the tested sample maps to the offered lot.

01

Material and lot identifiers agree across records

02

Testing facility and report date are visible

03

Methods and reported units are identified

04

Results are compared with an approved specification

05

Alterations and superseded versions remain traceable

06

Release authorization is separate from the laboratory report

WHAT WE WILL NOT CLAIM

Credibility includes
knowing what is unknown.

No invented purity

No percentage will appear without a verified report mapped to the specific lot.

No borrowed COAs

Documents from unrelated sellers or samples will not represent PMBio inventory.

No implied certification

Testing, accreditation, compliance, and approval will remain distinct statements.

No silent substitutions

Supplier, format, specification, and material changes require documented review.